Tímea Lázár, Eszter Radics, Marie Anne Engh, Cameron Turkel, Réka Tóth, Tamás Kói, Péter Hegyi, Szabolcs Kéri, András Attila Horváth
{"title":"How well do dementia risk scores predict dementia? A systematic review and meta-analysis.","authors":"Tímea Lázár, Eszter Radics, Marie Anne Engh, Cameron Turkel, Réka Tóth, Tamás Kói, Péter Hegyi, Szabolcs Kéri, András Attila Horváth","doi":"10.1007/s11357-026-02615-y","DOIUrl":null,"url":null,"abstract":"<p><p>In our systematic review and meta-analysis, we aimed to assess the predictive accuracy and clinical applicability of ten dementia risk assessment scores for incident dementia in cohort studies. Three of 10 risk scores had sufficient, comparable data for a meta-analysis. We analyzed the Cardiovascular Risk Factors Ageing and Dementia (CAIDE), Lifestyle for brain health (LIBRA), and Alzheimer's Disease Risk Index (ANU-ADRI) in middle- and older-aged baseline populations with short, medium, and long follow-up durations, starting free from dementia, with or without other health conditions. A total of 29 studies met our inclusion criteria; 13 were included in the meta-analyses. CAIDE performed best, particularly among middle-aged participants at baseline, with longer follow-up periods, yielding pooled areas under the curves (AUCs) of 0.74-0.76. ANU-ADRI showed stable, moderate predictive accuracy with AUCs of approximately 0.65-0.71. The original LIBRA showed the lowest discrimination, with AUCs ranging from 0.51 to 0.60, whereas the modified LIBRA performed better, with AUCs of 0.65-0.67 at short follow-up and a pooled AUC of 0.70 (95% CI 0.66-0.74) at medium follow-up. Dementia risk assessment scales show variable predictive performance across scores, baseline age, and follow-up duration, and may be useful for dementia risk stratification in clinical practice. As a substantial proportion of dementia risk is linked to potentially modifiable factors, identifying high-risk individuals may help guide timely risk-reduction strategies. Further prospective validation is needed across different populations and clinical settings.</p>","PeriodicalId":12730,"journal":{"name":"GeroScience","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GeroScience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11357-026-02615-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
In our systematic review and meta-analysis, we aimed to assess the predictive accuracy and clinical applicability of ten dementia risk assessment scores for incident dementia in cohort studies. Three of 10 risk scores had sufficient, comparable data for a meta-analysis. We analyzed the Cardiovascular Risk Factors Ageing and Dementia (CAIDE), Lifestyle for brain health (LIBRA), and Alzheimer's Disease Risk Index (ANU-ADRI) in middle- and older-aged baseline populations with short, medium, and long follow-up durations, starting free from dementia, with or without other health conditions. A total of 29 studies met our inclusion criteria; 13 were included in the meta-analyses. CAIDE performed best, particularly among middle-aged participants at baseline, with longer follow-up periods, yielding pooled areas under the curves (AUCs) of 0.74-0.76. ANU-ADRI showed stable, moderate predictive accuracy with AUCs of approximately 0.65-0.71. The original LIBRA showed the lowest discrimination, with AUCs ranging from 0.51 to 0.60, whereas the modified LIBRA performed better, with AUCs of 0.65-0.67 at short follow-up and a pooled AUC of 0.70 (95% CI 0.66-0.74) at medium follow-up. Dementia risk assessment scales show variable predictive performance across scores, baseline age, and follow-up duration, and may be useful for dementia risk stratification in clinical practice. As a substantial proportion of dementia risk is linked to potentially modifiable factors, identifying high-risk individuals may help guide timely risk-reduction strategies. Further prospective validation is needed across different populations and clinical settings.
在我们的系统综述和荟萃分析中,我们旨在评估队列研究中10种痴呆风险评估评分对痴呆事件的预测准确性和临床适用性。10个风险评分中有3个有足够的、可比较的数据进行meta分析。我们分析了心血管危险因素老化和痴呆(CAIDE),脑健康生活方式(LIBRA)和阿尔茨海默病风险指数(ANU-ADRI)在中老年基线人群中进行了短期,中期和长期随访,从无痴呆开始,有或没有其他健康状况。共有29项研究符合我们的纳入标准;13例纳入meta分析。CAIDE表现最好,特别是在基线的中年参与者中,随访时间较长,曲线下汇总面积(auc)为0.74-0.76。ANU-ADRI表现出稳定、中等的预测准确度,auc约为0.65-0.71。原始的LIBRA显示出最低的歧视,AUC范围为0.51至0.60,而改良的LIBRA表现更好,短期随访的AUC为0.65-0.67,中期随访的合并AUC为0.70 (95% CI 0.66-0.74)。痴呆风险评估量表在评分、基线年龄和随访时间方面表现出可变的预测性能,可能对临床实践中的痴呆风险分层有用。由于痴呆风险的很大一部分与潜在的可改变因素有关,识别高风险个体可能有助于指导及时的风险降低策略。需要在不同人群和临床环境中进行进一步的前瞻性验证。
GeroScienceMedicine-Complementary and Alternative Medicine
CiteScore
10.50
自引率
5.40%
发文量
182
期刊介绍:
GeroScience is a bi-monthly, international, peer-reviewed journal that publishes articles related to research in the biology of aging and research on biomedical applications that impact aging. The scope of articles to be considered include evolutionary biology, biophysics, genetics, genomics, proteomics, molecular biology, cell biology, biochemistry, endocrinology, immunology, physiology, pharmacology, neuroscience, and psychology.